Champix

Varenicline is a smoking cessation medicine. It is used together with behavior modification and counseling support to help you stop smoking.

Product dosage: 1mg
Package (num)	Per pill	Price	Buy
28	6.02 $	168.48 $ (0%)	🛒 Add to cart
56	5.22 $	336.96 $ 292.50 $ (13%)	🛒 Add to cart
84	4.86 $ Best per pill	505.44 $ 408.33 $ (19%)	🛒 Add to cart
Synonyms Chantix

Champix (varenicline) is a prescription medication specifically designed to assist adults in quitting smoking. It functions as a partial agonist, selectively targeting α4β2 nicotinic acetylcholine receptors in the brain. This dual mechanism of action both reduces withdrawal symptoms and diminishes the satisfaction derived from smoking, thereby supporting cessation efforts. It is a critical tool within a comprehensive smoking cessation program that should include behavioral support.

Features

• Active ingredient: Varenicline (as varenicline tartrate)
• Available in 0.5 mg and 1 mg film-coated tablets
• Partial agonist at α4β2 nicotinic acetylcholine receptors
• Prescription-only medication
• Standard 12-week treatment course, with option for additional 12 weeks for maintenance
• Pack sizes typically include a starter pack and continuing packs

Benefits

• Significantly increases the likelihood of long-term smoking abstinence compared to placebo.
• Alleviates nicotine withdrawal symptoms and cravings, making the quitting process more manageable.
• Reduces the rewarding and reinforcing effects of smoking if a lapse occurs.
• Supported by extensive clinical trial data demonstrating efficacy and safety.
• Can be used as part of a broader smoking cessation strategy that includes counseling.
• Helps break the psychological and physical addiction to nicotine.

Common use

Champix is indicated for smoking cessation in adults. It is intended for use by individuals who are motivated to quit smoking and is most effective when used as part of a comprehensive program that includes educational materials and behavioral support. Treatment should be initiated while the patient is still smoking, with a set quit date typically planned for the second week of therapy.

Dosage and direction

The dosage of Champix should be individualized and administered orally following a meal with a full glass of water to minimize potential gastrointestinal upset.

Dosing regimen:

• Days 1 to 3: 0.5 mg once daily.
• Days 4 to 7: 0.5 mg twice daily.
• Day 8 to end of treatment: 1 mg twice daily.

The standard treatment duration is 12 weeks. For patients who have successfully stopped smoking at the end of 12 weeks, an additional course of 12 weeks of treatment at 1 mg twice daily may be considered to further increase the likelihood of long-term abstinence. For patients who cannot tolerate adverse effects, dose reduction may be considered. Patients with severe renal impairment (estimated creatinine clearance <30 mL/min) should receive a maximum dose of 0.5 mg twice daily. Treatment is not recommended in patients with end-stage renal disease.

Precautions

Patients should be advised to set a target quit date within the first two weeks of treatment. Neuropsychiatric adverse events, including changes in behavior, agitation, depressed mood, and suicidal ideation, have been reported. Patients should be monitored for these symptoms, and treatment should be discontinued if they occur. Nausea is the most common adverse reaction; taking Champix with food and water can help manage it. Dose escalation as per the recommended schedule improves tolerability. Use caution in patients with a history of psychiatric illness. Patients should be advised to use caution when driving or operating machinery until they know how Champix affects them, as it may cause dizziness or somnolence.

Contraindications

Champix is contraindicated in individuals with a known hypersensitivity to varenicline or any component of the formulation. Its safety and efficacy in patients under 18 years of age have not been established.

Possible side effect

The most frequently reported adverse reactions are nausea, insomnia, abnormal dreams, headache, and constipation. Nausea is typically dose-related and often transient.

Very common (≥1/10): Nausea. Common (≥1/100 to <1/10): Abdominal pain, flatulence, vomiting, dyspepsia, constipation, dry mouth; insomnia, abnormal dreams, headache, dizziness, sleep disorder, anxiety, depressed mood, agitation, irritability; fatigue, malaise; increased appetite, decreased appetite; arthralgia, muscle cramps; rash, hyperhidrosis. Uncommon (≥1/1,000 to <1/100): Tachycardia, palpitations; chest pain; gingivitis; thirst; akathisia, mood swings, disorientation, restlessness, libido decreased, libido increased, panic attack, thinking abnormal, dysgeusia, somnolence, tremor, migraine, balance disorder; visual impairment, eye pain, conjunctivitis, eye irritation, blurred vision; tinnitus, vertigo; dyspnoea, cough, nasal congestion, rhinorrhoea; hypertension, hot flush; glycosuria; polyuria; nocturia; erectile dysfunction; menorrhagia; pruritus, urticaria, acne, erythema, photosensitivity reaction; neck pain; weight increased, chest discomfort, asthenia. Serious but rare side effects can include serious skin reactions (e.g., Stevens-Johnson Syndrome), angioedema, seizures, and cardiovascular events in patients with pre-existing cardiovascular disease. Patients should be instructed to discontinue Champix and seek immediate medical attention if they experience any signs of a serious allergic reaction.

Drug interaction

Formal drug-drug interaction studies showed no clinically significant pharmacokinetic interactions. However, based on its mechanism of action, varenicline has the potential for interaction with other cholinergic agents. Cimetidine may increase varenicline exposure. No dosage adjustment is needed for these interactions. Use caution when co-administering with drugs that are primarily renally excreted (e.g., metformin, ranitidine) as competition for renal tubular secretion could theoretically occur, though this is not expected to be clinically significant. Nicotine replacement therapy (NRT) concomitantly with Champix may increase the incidence of nausea, headache, vomiting, dizziness, dyspepsia, and fatigue.

Missed dose

If a dose is missed, it should be taken as soon as remembered, unless it is nearly time for the next dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Patients should not take a double dose to make up for a missed one.

Overdose

Cases of overdose have been reported. Signs and symptoms are likely to be an extension of its adverse reaction profile, including nausea and possibly emesis. There is no specific antidote for varenicline overdose. In cases of overdose, standard supportive measures should be initiated as required. Due to the substantial renal elimination of varenicline, dialysis may be useful in severe cases, though this has not been studied.

Storage

Store at room temperature between 15°C and 30°C (59°F and 86°F). Keep the blister strips in the original outer carton to protect from light and moisture. Keep out of the sight and reach of children. Do not use after the expiration date printed on the pack.

Disclaimer

This information is for educational purposes only and does not constitute medical advice. Champix is a prescription medication. A healthcare professional must diagnose your condition and determine the appropriate treatment. Always follow the dosage and instructions provided by your doctor or the product label. Do not start, stop, or change the dosage of any medicine without consulting your healthcare provider. Report any side effects to your doctor immediately.

Reviews

“After two decades of smoking, Champix provided the support I needed to finally quit. The structured dosing and reduction in cravings were fundamental to my success. The initial nausea was manageable with food.” - M.K., 45 “As a physician, I prescribe Champix as a first-line pharmacological aid for motivated patients. Its efficacy is well-documented in clinical literature. The key is combining it with behavioral counseling for the highest success rates.” - Dr. A. Sharma “The first week was an adjustment, but sticking to the schedule made all the difference. I’ve been smoke-free for eight months now, something I never thought possible with previous methods like cold turkey or patches.” - J.L., 38 “While effective, it’s not a magic pill. Patients must be committed to quitting. The potential for neuropsychiatric events, though rare, necessitates careful patient selection and monitoring throughout the treatment course.” - Clinical Pharmacist Review